Evidence map›Paper›PMID 41066429›Full record

ArticlePloS one2025

Combined metabolomics and proteomics analysis of vascular cognitive impairment in hypertensive rats induced by endothelial injury.

Xiao Zhang, Surui Chang, Jiangang Liu, Dongling Wang

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiao ZhangXiyuan Hospital, China Academy of Chinese Medical Sciences, National Center for Clinical Cardiovascular Disease of Traditional Chinese Medicine, Beijing, China.
Surui ChangXiyuan Hospital, China Academy of Chinese Medical Sciences, National Center for Clinical Cardiovascular Disease of Traditional Chinese Medicine, Beijing, China.
Jiangang LiuXiyuan Hospital, China Academy of Chinese Medical Sciences, National Center for Clinical Cardiovascular Disease of Traditional Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0002-2313-4592
Dongling WangXiyuan Hospital, China Academy of Chinese Medical Sciences, National Center for Clinical Cardiovascular Disease of Traditional Chinese Medicine, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimBased on metabolomics and proteomics research, we investigate the molecular biological mechanisms underlying vascular cognitive impairment (VCI) in rats induced by hypertension combined with endothelial damage, aiming to identify proteins or metabolites associated with key metabolic pathways.

methodsSPF hypertensive rats (SHR) were used to damage the common carotid artery endothelium with microcurrent to induce vascular cognitive impairment model in rats (Model group), SHR rats (SHR group) and SPF normotensive Wistar-Kyoto rats (WKY) with the same genetic background were used as sham operation groups (no current stimulation after dissection), with 10 rats in each group. Morris water maze, PNT experiment and SPT experiment were used to detect the learning and memory ability of rats. TMT quantitative proteomics technology combined with liquid chromatography tandem mass spectrometry (LC-MS/MS) was used to detect the difference in metabolites and proteins in brain tissue of rats with vascular cognitive impairment.

resultsFrom Day 1-5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (P < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (P < 0.05), time spent in the target quadrant (P < 0.05), and total distance traveled in the target quadrant (P < 0.05). Pathological results revealed that, compared with the WKY group, the SHR group and Model group exhibited a decrease in the number of glial cells and neurons in the hippocampal tissue, with relatively loose arrangement of cell bodies and lighter Nissl staining. In the Model group, some hippocampal neurons changed from a granular to a powdery appearance, with nuclear pyknosis, accompanied by cellular edema and necrosis. The metabolomics results showed that there were 437 significantly different metabolites between the Model group and the WKY group, 128 (+) and 309 (-); there were 449 significantly different metabolites between the Model group and the SHR group, 119 (+), 330(-). The differential metabolites in each group were mainly concentrated in metabolic pathways such as alanine, aspartate and glutamate metabolism, arginine and proline metabolism, and amino acid biosynthesis. The proteomics results showed that compared with the WKY group, there were 141 differentially expressed proteins in the Model group, 55 (+), and 86 (-). Pathways with higher connectivity in the action network include "glycine, serine and threonine metabolism", "phenylalanine metabolism", etc.; compared with the SHR group, there were 28 differentially expressed proteins in the Model group and 15 (+). 13 species (-). The significantly enriched pathways are "focal adhesion" and "relaxin signaling pathway".

conclusionRats with hypertension combined with endothelial injury have behavioral disorders, which are similar to the causes and signs of clinical vascular cognitive impairment; the biological mechanisms manifested in the model involve amino acid metabolism disorders, energy metabolism, relaxin signaling pathway and impaired focal adhesion function. Characteristic metabolites in the model group, such as ATP, cAMP, Creatine, Cyanocobalamin, Dopamine, Serotonin, Tryptophan, Uric acid and Vitamin B1 decreased, while GABA, Glucose, Isocitrate and Malate increased.

Indexed as

Cognitive DysfunctionDementia, VascularEndothelium, VascularHypertensionMetabolomicsProteomicsAnimalsDisease Models, AnimalHippocampusMaleMaze LearningRatsRats, Inbred SHRRats, Inbred WKY

Identifiers

PMID41066429
PMCPMC12510566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.